Cargando…

Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study

BACKGROUND: To assess the impact of changes in different glucose tolerance states on risk of incident cardiovascular disease (CVD)/coronary heart disease (CHD). METHODS: A total of 4094 Iranians (43.9% men) aged ≥ 30 years, without diabetes and CVD at enrolment were included. The following categorie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabootari, Maryam, Hasheminia, Mitra, Azizi, Fereidoun, Mirbolouk, Mohammadhassan, Hadaegh, Farzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106714/ https://www.ncbi.nlm.nih.gov/pubmed/32228577 http://dx.doi.org/10.1186/s12933-020-01017-4

Ejemplares similares

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
por: Barzegar, Niloofar, et al.
Publicado: (2020)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
por: Rasooli, Rahele, et al.
Publicado: (2022)

Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study
por: Kabootari, Maryam, et al.
Publicado: (2019)

Impact of 3-year changes in fasting insulin and insulin resistance indices on incident hypertension: Tehran lipid and glucose study
por: Baghbani-Oskouei, Aidin, et al.
Publicado: (2019)

Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study
por: Khaloo, Pegah, et al.
Publicado: (2018)

Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2022)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Association between Wrist Circumference and Risk of Any Fracture in Adults: Findings from 15 Years of Follow-Up in the Tehran Lipid and Glucose Study
por: Tamehri Zadeh, Seyed Saeed, et al.
Publicado: (2022)

Change in blood pressure status defined by 2017 ACC/AHA hypertension guideline and risk of cardiovascular disease: results of over a decade of follow-up of the Iranian population
por: Kabootari, Maryam, et al.
Publicado: (2023)

Adolescent metabolic syndrome and its components associations with incidence of type 2 diabetes in early adulthood: Tehran lipid and glucose study
por: Asghari, Golaleh, et al.
Publicado: (2021)

Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study
por: Mohammadreza, Bozorgmanesh, et al.
Publicado: (2012)

Resting heart rate and the risk of incident type 2 diabetes mellitus among non-diabetic and prediabetic Iranian adults: Tehran lipid and glucose study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2023)

Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2020)

Three-year weight change and risk of all-cause, cardiovascular, and cancer mortality among Iranian adults: over a decade of follow-up in the Tehran Lipid and Glucose Study
por: Deravi, Niloofar, et al.
Publicado: (2022)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

The association of priori and posteriori dietary patterns with the risk of incident hypertension: Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2021)

Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
por: Abdi, Hengameh, et al.
Publicado: (2018)

Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010)

Sex specific trajectories of central adiposity, lipid indices, and glucose level with incident hypertension: 12 years Follow-up in Tehran lipid and glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2021)

Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2023)

Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study
por: Masudi, Sima, et al.
Publicado: (2015)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2010)

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2021)

Tobacco Smoking: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Parizadeh, Donna, et al.
Publicado: (2018)

Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran
por: Eslami, Ali, et al.
Publicado: (2019)

Beta-Cell Age Calculator, a Translational Yardstick to Communicate Diabetes Risk with Patients: Tehran Lipid and Glucose Study
por: Bozorgmanesh, Mohammadreza, et al.
Publicado: (2012)

Sex differences in the association between diabetes and hypertension and the risk of stroke: cohort of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2022)

High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2008)

Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study
por: Kabootari, Maryam, et al.
Publicado: (2021)

Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases
por: Baghbani-Oskouei, Aidin, et al.
Publicado: (2018)

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016)

Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study
por: Hashemi, Ashkan, et al.
Publicado: (2018)

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
por: Rabani, SeyedHossein, et al.
Publicado: (2018)

The association between dietary fats and the incidence risk of cardiovascular outcomes: Tehran Lipid and Glucose Study
por: Gaeini, Zahra, et al.
Publicado: (2021)

Sex Differences in Cumulative Exposure to Metabolic Risk Factors Before Hypertension Onset: The Cohort of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3tt3onhdgdm7hgd2gf7q3a64ls